Boston Scientific
- Market cap
- 60.26B
- P/E (TTM)i
- 16.83
- P/Bi
- 2.42
- EPSi
- 1.94
- Div yieldi
- 0.00%
- 52W posi
- 0%
Anonymous reader poll. Unscientific, not investment advice.
Boston Scientific shares were changing hands at 41.58, down 1.45% on the day. That leaves the company valued at approximately 60.26B, the #364 most valuable US-listed company we track. Valuation-wise, the P/E sits at 17.17, 75% below the five-year average of 67.63. Across 21 analysts the consensus rating is Buy, with an average price target of 58.58 (+41%). Against a 52-week band of 41.50-105.65, the shares are currently 0% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 8 months.
- Its last 3 Sell calls were actually followed by a +6% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -32.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 3.2% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 17.2x | Better than 56% |
| Forward P/E | 18.0x | Better than 48% |
| Price / Sales | 3.0x | Better than 50% |
| P/E vs own 5-yr range | 0th pctl | Better than 100% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 16.5% | Better than 80% |
| Net income CAGR (3Y) | 60.7% | Better than 93% |
| Free cash flow CAGR (3Y) | 55.0% | Better than 88% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 69.0% | Better than 82% |
| Operating margin | 19.8% | Better than 64% |
| Net margin | 14.4% | Better than 61% |
| Return on equity | 12.6% | Better than 48% |
| Return on invested capital | 9.2% | Better than 53% |
Momentum D-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -6.4% | Better than 37% |
| 6-month return | -31.5% | Better than 4% |
| 12-month return (ex latest month) | -50.6% | Better than 2% |
| Distance below 52-week high | 59.9% | Better than 3% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.6x | Better than 56% |
| Debt to assets | 47.2% | Better than 30% |
| Interest coverage | 10.7x | Better than 65% |
| Free cash flow / net income | 117.5% | Better than 54% |
Analyst View A-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 85.7% | Better than 66% |
| Upside to average target | 38.2% | Better than 72% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 42.19
- Open
- 42.19
- Day range
- 41.50 - 42.52
- Avg price
- 41.97
- Volume
- 15.89M
- Turnover
- 667.00M
- Turnover ratei
- 1.10%
- Volume ratioi
- 0.98
- Amplitudei
- 2.41%
- 52-week rangei
- 41.50 - 105.65
Valuation
- P/Ei
- 21.43
- P/E (TTM)i
- 16.83
- P/Bi
- 2.42
- EPSi
- 1.94
- Book value / shi
- 17.20
- Net profit
- 2.81B
- Net assets
- 24.93B
Share structure
- Market cap
- 60.26B
- Float capi
- 60.08B
- Shares out
- 1.45B
- Float sharesi
- 1.44B
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
60.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-373.72M net over the window
Short interest
- Shares short
- 46.50M
- % of floati
- 3.21%
- Days to coveri
- 2.35
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Boston Scientific (BSX)?
Boston Scientific last traded at 41.58. The quote on this page refreshes every few seconds while US markets are open.
What is Boston Scientific's market cap?
About 60.26B.
What is the P/E ratio of Boston Scientific?
The trailing twelve-month P/E is 16.83, below its own 5-year average of 67.63 — toward the bottom of its historical range (0.08% percentile). See the Valuation tab for the full history.
Does Boston Scientific pay a dividend?
Boston Scientific does not currently pay a regular dividend.
Is Boston Scientific a buy according to analysts?
The consensus of 21 analysts is a Buy rating, with an average 12-month price target of 58.58, which implies 40.9% upside from the current price. This is not investment advice.
What is Boston Scientific's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Boston Scientific a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-10-08 06:38:27 · For reference only, not investment advice and not tailored to your situation.